Literature DB >> 3458722

McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.

R T Bogusky, R G Taylor, L J Anderson, K L Angelos, J S Lieberman, D A Walsh.   

Abstract

Two daughters of a propositus with documented McArdle's disease were shown by enzyme assay, gel electrophoresis, and immunoblotting to be partially deficient in skeletal muscle phosphorylase and, presumably, heterozygous for the trait. Both exhibited only the adult form of the skeletal muscle isozyme. By 31P-nuclear magnetic resonance, both heterozygotes showed a greater production of acid during fully aerobic exercise than when blood flow was occluded in ischemic exercise. This pattern is in contrast to that of control subjects, where there is significantly greater acid production in ischemic versus aerobic exercise, and distinct from that of phosphorylase-negative patients in which no acid is produced in either circumstance. We suggest that these heterozygotes may have adapted to their diminished phosphorylase by enhancing utilization of plasma glucose. If so, this mechanism could account for the observation that most of the symptoms of McArdle's disease are often manifest only in adulthood. These studies also show that although there are very high concentrations of phosphorylase in skeletal muscle (approximately 2% of the soluble protein), such a high level is essential for normal muscle glycogenolysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458722      PMCID: PMC370547          DOI: 10.1172/JCI112515

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  A metabolic myopathy due to absence of muscle phosphorylase.

Authors:  C M PEARSON; D G RIMER; W F MOMMAERTS
Journal:  Am J Med       Date:  1961-04       Impact factor: 4.965

3.  A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

Authors:  W F Mommaerts; B Illingworth; C M Pearson; R J Guillory; K Seraydarian
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

4.  Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease.

Authors:  K Sato; F Imai; I Hatayama; R I Roelofs
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Glucose intolerance and aging: evidence for tissue insensitivity to insulin.

Authors:  R A Defronzo
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

7.  Developmental changes of glycogen phosphorylase b isozymes in rat tissues.

Authors:  F Richter; H J Böhme; E Hofmann
Journal:  Biomed Biochim Acta       Date:  1983

8.  Adenylate deaminase from rat muscle. Regulation by purine nucleotides and orthophosphate in the presence of 150 mM KCl.

Authors:  T J Wheeler; J M Lowenstein
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

9.  McArdle disease: the mystery of reappearing phosphorylase activity in muscle culture--a fetal isoenzyme.

Authors:  S DiMauro; S Arnold; A Miranda; L P Rowland
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

10.  Cyclic AMP-dependent and cyclic AMP-independent antagonism of insulin activation of cardiac glycogen synthase.

Authors:  C Ramachandran; K L Angelos; D A Walsh
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

View more
  1 in total

1.  Non-invasive 31P magnetic resonance spectroscopy revealed McArdle disease in an asymptomatic child.

Authors:  R Gruetter; P Kaelin; C Boesch; E Martin; B Werner
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.